(Q30414135)

English

Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

electroporation

1 reference

based on heuristic

inferred from title

Gary P. Kobinger

4

object named as

Gary Kobinger

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Kate E. Broderick

7

object named as

Kate E Broderick

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Alexander Bello

5

object named as

Alexander Bello

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Xuefei Shen

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jonas Söderholm

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Feng Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Derek A Gregg

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Niranjan Y Sardesai

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

8 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6946-6954

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Influenza: evolving strategies in treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

A history of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Influenza viruses and the evolution of avian influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Research and development of universal influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Electroporation delivery of DNA vaccines: prospects for success

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Biochemistry of human skin--our brain on the outside

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Dendritic cells: biology of the skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

A constant rate of spontaneous mutation in DNA-based microbes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Expression of transfected DNA depends on DNA topology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Study of mechanisms of electric field-induced DNA transfection. V. Effects of DNA topology on surface binding, cell uptake, expression, and integration into host chromosomes of DNA in the mammalian cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

DNA supercoiling: Another level for regulating gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Transformation ofEscherichia coliwith large DNA molecules by electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.071

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.02.071

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30414135&oldid=1990377546"